Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 68

Sort by

Sort Order Select

Journal Articles

Outcome of Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Evaluation of a PET-Adapted Approach

Phoebe Tsz Man Cheng, BSc,MD, Diego Villa, MD MPH, R. Petter Tonseth, MD, David W. Scott, MBChB, PhD, Alina S Gerrie, MD MPH, Ciara L Freeman, MSc, MBBChir, Christina Aquino Parsons, MD, Tom Pickles, MD, Andrea Lo, MD, Don Wilson, MD, Brian Skinnider, MD, Laurie H Sehn, MD, Joseph M Connors, MD, Kerry J Savage, BSc, MD MSc

Blood (2019) 134 (Supplement_1): 2845.

https://doi.org/10.1182/blood-2019-122019

Published: 2019

Journal Articles

Classical Hodgkin Lymphoma Patients Have an Increased Incidence of Idiopathic Acquired Aplastic Anemia

Taylor Linaburg, BSc, Adam R. Davis, MD, Noelle V. Frey, MD, Daniel J. Landsburg, MD, Stephen J. Schuster, MD, Jakub Svoboda, MD, Yimei Li, PhD, Yuliya Borovskiy, MS, Timothy S. Olson, MD PhD, Adam Bagg, MD, Elizabeth O. Hexner, MD MS, Daria V. Babushok, MD PhD

Blood (2018) 132 (Supplement 1): 5098.

https://doi.org/10.1182/blood-2018-99-110032

Published: 2018

Journal Articles

Dilemma-High Response Rates Vs High Toxicity: Autologous Stem Cell Transplantation for Lymphoma

Erden Atilla, MD, Selami Kocak Toprak, MD, Sinem Civriz Bozdag, MD, Meltem Yuksel, MD, Pervin Topcuoglu, MD, Hamdi Akan, MD, Onder Arslan, MD, Taner Demirer, MD, Meral Beksac, MD, Osman Ilhan, MD, Muhit Ozcan, MD, Gunhan Gurman, MD

Blood (2017) 130 (Supplement 1): 5528.

https://doi.org/10.1182/blood.V130.Suppl_1.5528.5528

Published: 2017

Journal Articles

Can We Improve the Predictive Value of Interim PET/CT Using a New Prognostic Model for Advanced Hodgkin Lymphoma?

Eldad J. Dann, MD, Osnat Bairey, MD, Rachel Bar-Shalom, MD, Tanya Mashiach, MSc, Elinor Barzilai, BSc, Abraham Korenberg, MD, Luiza Akria, MD, Tamar Tadmor, MD, Kalman Filanovsky, MD, Uri Abadi, MD, Olga Kagna, MD, Rosa Ruchlemer, MD, Neta Goldschmidt, MD, Netanel A. Horowitz, MD, David Lavie, MD, Dina Ben-Yehuda, MD, Ofer Shpilberg, MD, Ora B. Paltiel, MDM, MSc

Blood (2016) 128 (22): 3001.

https://doi.org/10.1182/blood.V128.22.3001.3001

Published: 2016

Journal Articles

Interim Absolute Lymphocyte Count (ALC) As a Predictor of Survival in Hodgkin Lymphoma

Tarsheen K. Sethi, MD MS, Van T Nguyen, MD, David S Morgan, MD, John P. Greer, MD, Nishitha M Reddy, M.B.B.S.

Blood (2015) 126 (23): 2640.

https://doi.org/10.1182/blood.V126.23.2640.2640

Published: 2015

Journal Articles

Late Relapse in Hodgkin Lymphoma (HL): A Retrospective Analysis of Patients Enrolled on Clinical Trials at the Istituto Nazionale Tumori of Milan (INT-MI)

Simonetta Viviani, MD, Alberto Mussetti, MD, Oreste Di Bartolo, MD, Antonello Cabras, MD, Pinuccia Valagussa, Statistician, Gianni Bonadonna, MD, Alessandro M. Gianni, MD, Paolo Corradini, MD

Blood (2015) 126 (23): 2697.

https://doi.org/10.1182/blood.V126.23.2697.2697

Published: 2015

Journal Articles

Neutrophil - Lymphocyte Ratio (NLR) at Diagnosis Is an Independent Prognostic Factor in Patients with Nodular Sclerosis Hodgkin Lymphoma: Results of a Large Multicenter Study Involving 990 Patients

Alessia Bari, Luigi Marcheselli, Tamar Tadmor, Raffaella Marcheselli, Maria Christina Cox, MDPhD, Samantha Pozzi, Angela Ferrari, Luca Baldini, Paolo Gobbi, Massimo Federico, Aaron Polliack, Stefano Sacchi

Blood (2015) 126 (23): 3862.

https://doi.org/10.1182/blood.V126.23.3862.3862

Published: 2015

Journal Articles

Differences in Outcome of Patients with Syncytial Variant Hodgkin Lymphoma (HL) Compared with Typical Nodular Sclerosis HL

Tarsheen K. Sethi, MD MS, Van T Nguyen, MD, Shaoying Li, MD, David S Morgan, MD, John P. Greer, MD, Nishitha M Reddy, M.B.B.S.

Blood (2015) 126 (23): 1441.

https://doi.org/10.1182/blood.V126.23.1441.1441

Published: 2015

Journal Articles

Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder (HL-PTLD) after Solid Organ Transplant (SOT): A Comprehensive and Comparative Analysis of Disease Characteristics, Prognosis, and Survival

Aaron S. Rosenberg, MD, Andreas K. Klein, MD, Robin Ruthazer, MPH, Andrew M. Evens, DO, MSc

Blood (2014) 124 (21): 502.

https://doi.org/10.1182/blood.V124.21.502.502

Published: 2014

Journal Articles

Long-Term Follow-up Analysis of HD2000 Trial Comparing ABVD Versus BEACOPP Versus Copp/EBV/CAD in Patients with Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study from the Fondazione Italiana Linfomi

Francesco Merli, MD, Stefano Luminari, MD, Caterina Mammi, PhD, Nicola Cascavilla, MD, Alessia Bari, MD, Caterina Stelitano, MD, Renato Scalone, MD, Luca Baldini, Prof, Francesco Angrilli, MD, Giuseppe Polimeno, MD, Paolo G Gobbi, Prof, Giulia Cervetti, MD, Fiorella Ilariucci, MD, Alessia Ruffini, Luigi Marcheselli, Massimo Federico, MD

Blood (2014) 124 (21): 499.

https://doi.org/10.1182/blood.V124.21.499.499

Published: 2014

Journal Articles

Hodgkin’s Disease (1975-2012): Long-Term Results of a Single Center

Tiraje Celkan, Gül Nihal Özdemir, Hilal Akı, Hilmi Apak, Alp Özkan, Metin Hallaç, İbrahim Adaletli, Rahşan Özcan, Şefika Arzu Ergen, İnci Yıldız

Blood (2014) 124 (21): 5362.

https://doi.org/10.1182/blood.V124.21.5362.5362

Published: 2014

Journal Articles

Combined Modality Approach for Early Stage Unfavorable Hodgkin Lymphoma- Can We Avoid Radiation Therapy Based on Interim PET Imaging?

Van T Nguyen, MD, Judy P Tsai, MD, John P Greer, MD, David S Morgan, MD, Nishitha M Reddy, M.B.B.S.

Blood (2014) 124 (21): 5430.

https://doi.org/10.1182/blood.V124.21.5430.5430

Published: 2014

Journal Articles

Pediatric Hodgkin Lymphoma-Treatment Outcome with COPDac/ABVD Combination Chemotherapy – Single Institution Experience

Mehboob Ahmed, Shazia Riaz, MD, Syed Nasir Abbas, Fahim Rehman

Blood (2014) 124 (21): 5449.

https://doi.org/10.1182/blood.V124.21.5449.5449

Published: 2014

Journal Articles

Trend Analysis of Clinical Outcomes in Hodgkin Lymphoma over the Last Three Decades: Report from the Nebraska Lymphoma Study Group

Kailash Mosalpuria, MD MPH, Fausto R Loberiza, MD MS, R. Gregory Bociek, MD, Matthew A. Lunning, DO, Apar Kishor Ganti, MD, James Olen Armitage, MD, Julie M. Vose, MD, Philip Bierman, MD

Blood (2014) 124 (21): 1284.

https://doi.org/10.1182/blood.V124.21.1284.1284

Published: 2014

Journal Articles

Genome-Wide DNA Methylation Analysis Reveals Epigenetic Deregulation of Key Biological Pathways in Therapy-Related Myeloid Neoplasms

Orsolya Lautner-Csorba, PhD, Jason Sotzen, Fabiani Emiliano, Fianchi Luana, Stefan Hohaus, MD, Giuseppe Leone, MD, Maria Teresa Voso, Maria E Figueroa, MD

Blood (2014) 124 (21): 3542.

https://doi.org/10.1182/blood.V124.21.3542.3542

Published: 2014

Journal Articles

Absolut Lymphocyte Count At Diagnosis Is Predictive Of Survival In Patients With Classical Hodgkin Lymphoma: A Retrospective Multicenter Brazilian Study

Guilherme Fleury Perini, MD, Egyla M Cavalcante, MD, Joao Garibaldi Rezende, Jr., MD, Davimar Miranda Borducchi, MD, Fernanda Cunha Vieira, MD, Danielle Leão Cordeiro Faria, MD, MS, Renato S Tavares, MD, Camila Almeida Amaral, Fabio S P Santos, MD, Nelson Hamerschlak, MD, PhD, Karin Zattar Cecyn, Eni Maria Souza, M.D, PhD, Adriana M. Damasco Penna, M.D, Otavio C.G. Baiocchi, MD, PhD

Blood (2013) 122 (21): 4236.

https://doi.org/10.1182/blood.V122.21.4236.4236

Published: 2013

Journal Articles

Systematic Review and Individual Patient Data Meta-Analysis Of Treatment-Related Risk Of Secondary Malignant Neoplasms After Hodgkin Lymphoma

Jeremy Franklin, PhD, Dennis A. Eichenauer, MD, Ingrid Becker, MSc, Andreas Engert, MD

Blood (2013) 122 (21): 1753.

https://doi.org/10.1182/blood.V122.21.1753.1753

Published: 2013

Journal Articles

Diffuse Large B-Cell Transformation in Nodular Lymphocyte Predominant Hodgkin Lymphoma: Incidence, Risk Factors and Outcomes After a Forty-Year Experience From a Single Institution

Saad J. Sirop, MD, Thomas M Habermann, MD, William R Macon, MD, Kay M. Ristow, Stephen M Ansell, MD, PhD, Joseph P Colgan, MD, Patrick B. Johnston, MD, PhD, David J. Inwards, MD, Svetomir N. Markovic, MD, PhD, Ivana N. Micallef, MD, Carrie Thompson, MD, Luis F. Porrata, MD, James A. Martenson, Jr., MD, James R Cerhan, MD, PhD, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD

Blood (2012) 120 (21): 1525.

https://doi.org/10.1182/blood.V120.21.1525.1525

Published: 2012

Journal Articles

Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Blood Stem-Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma: Excellent Disease Control and Long-Term Survival Rates

Ryan D. Gentzler, MD, MS, Andrew M. Evens, DO, MSc, Alfred W. Rademaker, PhD, Bharat B Mittal, M.D., Adam M. Petrich, MD, Jessica K. Altman, MD, Olga Frankfurt, MD, Daina Variakojis, MD, Seema Singhal, M.D., Jayesh Mehta, MD, Joel R Green, MD, Stephanie Williams, MD, Lynne Kaminer, MD, Leo I. Gordon, MD, Jane N. Winter, MD

Blood (2012) 120 (21): 2024.

https://doi.org/10.1182/blood.V120.21.2024.2024

Published: 2012

Journal Articles

Pretreatment Serum Cytokines Predict Early Disease Relapse and A Poor Prognosis In Newly Diagnosed Classical Hodgkin Lymphoma (cHL) Patients

Stephen M. Ansell, MD, PhD, Matthew J Maurer, MS, Steven C. Ziesmer, Susan L Slager, PhD, Thomas M. Habermann, MD, Brian K Link, MD, Thomas E. Witzig, MD, David James Inwards, MD, Joseph P. Colgan, MD, James R Cerhan, MD, PhD, Anne J. Novak, Ph.D.

Blood (2011) 118 (21): 429.

https://doi.org/10.1182/blood.V118.21.429.429

Published: 2011

NARROW

Outcome of Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Evaluation of a PET-Adapted Approach

Classical Hodgkin Lymphoma Patients Have an Increased Incidence of Idiopathic Acquired Aplastic Anemia

Dilemma-High Response Rates Vs High Toxicity: Autologous Stem Cell Transplantation for Lymphoma

Can We Improve the Predictive Value of Interim PET/CT Using a New Prognostic Model for Advanced Hodgkin Lymphoma?

Interim Absolute Lymphocyte Count (ALC) As a Predictor of Survival in Hodgkin Lymphoma

Late Relapse in Hodgkin Lymphoma (HL): A Retrospective Analysis of Patients Enrolled on Clinical Trials at the Istituto Nazionale Tumori of Milan (INT-MI)

Neutrophil - Lymphocyte Ratio (NLR) at Diagnosis Is an Independent Prognostic Factor in Patients with Nodular Sclerosis Hodgkin Lymphoma: Results of a Large Multicenter Study Involving 990 Patients

Differences in Outcome of Patients with Syncytial Variant Hodgkin Lymphoma (HL) Compared with Typical Nodular Sclerosis HL

Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder (HL-PTLD) after Solid Organ Transplant (SOT): A Comprehensive and Comparative Analysis of Disease Characteristics, Prognosis, and Survival

Long-Term Follow-up Analysis of HD2000 Trial Comparing ABVD Versus BEACOPP Versus Copp/EBV/CAD in Patients with Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study from the Fondazione Italiana Linfomi

Hodgkin’s Disease (1975-2012): Long-Term Results of a Single Center

Combined Modality Approach for Early Stage Unfavorable Hodgkin Lymphoma- Can We Avoid Radiation Therapy Based on Interim PET Imaging?

Pediatric Hodgkin Lymphoma-Treatment Outcome with COPDac/ABVD Combination Chemotherapy – Single Institution Experience

Trend Analysis of Clinical Outcomes in Hodgkin Lymphoma over the Last Three Decades: Report from the Nebraska Lymphoma Study Group

Genome-Wide DNA Methylation Analysis Reveals Epigenetic Deregulation of Key Biological Pathways in Therapy-Related Myeloid Neoplasms

Absolut Lymphocyte Count At Diagnosis Is Predictive Of Survival In Patients With Classical Hodgkin Lymphoma: A Retrospective Multicenter Brazilian Study

Systematic Review and Individual Patient Data Meta-Analysis Of Treatment-Related Risk Of Secondary Malignant Neoplasms After Hodgkin Lymphoma

Diffuse Large B-Cell Transformation in Nodular Lymphocyte Predominant Hodgkin Lymphoma: Incidence, Risk Factors and Outcomes After a Forty-Year Experience From a Single Institution

Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Blood Stem-Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma: Excellent Disease Control and Long-Term Survival Rates

Pretreatment Serum Cytokines Predict Early Disease Relapse and A Poor Prognosis In Newly Diagnosed Classical Hodgkin Lymphoma (cHL) Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only